Corteva and Hexagon Bio Form Multi-Million-Dollar Joint Venture to Advance Nature-Inspired Crop Protection
19 December 2025, California: Corteva, Inc. and Hexagon Bio have announced a multi-million-dollar joint venture aimed at accelerating the discovery and development of new nature-inspired crop protection solutions. The collaboration brings together Corteva’s crop protection expertise and natural product discovery capabilities with Hexagon Bio’s proprietary platform for identifying novel biologically derived molecules.
The joint venture marks Hexagon Bio’s first partnership in the agriculture sector and Corteva’s first collaboration of this kind bridging agricultural and pharmaceutical discovery approaches. Through the JV, both companies will advance their respective innovation pipelines across agriculture and human health.
Corteva will contribute its established portfolio of nature-inspired crop protection products and its experience in bacterial natural product discovery. Hexagon Bio will provide access to its discovery platform, which integrates microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterise new natural products with diverse modes of action.
According to Corteva, the partnership is expected to strengthen its research pipeline and support the development of next-generation crop protection tools that respond to evolving pest and disease pressures while aligning with growing demand for sustainable solutions in agriculture.
Hexagon Bio stated that the collaboration allows the company to expand the application of its discovery platform beyond human health, enabling parallel development of agricultural solutions while continuing its core focus on natural product-based medicines.
Natural products have historically played a significant role in both agriculture and medicine, forming the basis of widely used antibiotics, cancer therapies, fungicides, and insecticides. Advances in genomics, data science, and synthetic biology are further expanding the potential of nature-derived molecules for crop protection and health applications.
The joint venture has been formed through Corteva Catalyst, Corteva’s investment and collaboration platform. Since its launch in March 2024, Corteva Catalyst has partnered with 11 companies globally, with investments spanning biologicals, gene editing, and emerging agricultural technology platforms.
Also Read: BASF | Nunhems to Acquire Noble Seeds, Expanding Presence in India’s Vegetable Seed Market
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
